Form 4: QuidelOrtho CHRO's RSU Vesting & Tax Withholding
Insider Transaction Report
QuidelOrtho's Chief Human Resources Officer, Ronald Lee Bowman, reported the vesting of 2,565 restricted stock units and the subsequent sale of 918 shares for tax obligations.
Summary
- Ronald Lee Bowman, Chief Human Resources Officer of QuidelOrtho Corp (QDEL), reported changes in beneficial ownership.
- On September 15, 2025, 2,565 restricted stock units (RSUs) vested, converting into common stock.
- Concurrently, 918 shares of common stock were disposed of at a price of $28.92 per share to satisfy tax withholding obligations related to the RSU vesting.
- Following these transactions, Ronald Lee Bowman directly owns 1,647 shares of common stock.
- An additional 5,132 restricted stock units remain beneficially owned, with future vesting scheduled in equal installments on September 15, 2026, and September 15, 2027.
Sentiment
Score: 6
Explanation: The filing reports a routine executive compensation event (RSU vesting) and a subsequent tax-related share disposition. This is a neutral to slightly positive event as it reflects ongoing executive compensation and alignment, with no unexpected negative implications.
Positives
- The vesting of restricted stock units represents a scheduled compensation event for the Chief Human Resources Officer, indicating continued executive alignment with shareholder interests through equity ownership.
Negatives
- A disposition of 918 shares occurred to cover tax withholding obligations, which is a routine event but reduces the executive's direct share count.
Future Outlook
Future vesting of 5,132 restricted stock units is scheduled to occur in equal installments on September 15, 2026, and September 15, 2027.
Industry Context
This is a routine insider transaction related to executive compensation and does not directly reflect broader industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders: The transaction is a routine part of executive compensation and does not indicate a significant change in company strategy or financial health. The sale for tax purposes is common and not typically a signal of lack of confidence.
- Employees: Reflects standard executive compensation practices.
Next Steps
- Future vesting of 5,132 restricted stock units in equal installments on September 15, 2026, and September 15, 2027.
Key Dates
| Date | Description |
|---|---|
| 09/15/2025 | Date of RSU vesting and related common stock transactions. |
| 09/17/2025 | Date the Form 4 was signed. |
| 09/15/2026 | Scheduled vesting date for a portion of the remaining restricted stock units. |
| 09/15/2027 | Scheduled vesting date for the final portion of the remaining restricted stock units. |
Recommendation
holdThe filing details a routine insider transaction involving the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations. This is a standard compensation event for an executive and does not provide new material information that would warrant a change in investment thesis or a strong buy/sell recommendation. It is a neutral event for the stock's valuation.
Keywords
QDEL, QuidelOrtho, Form 4, Insider Transaction, RSU, Restricted Stock Units, Executive Compensation, Ronald Lee Bowman, Stock Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.